No abstract available
Keywords:
Anti-epileptic drugs; Direct-acting antivirals; Glecaprevir/pibrentasvir; Hepatitis C virus; Sofosbuvir/velpatasvir.
MeSH terms
-
Antiviral Agents* / therapeutic use
-
Benzimidazoles / therapeutic use
-
Genotype
-
Hepacivirus / genetics
-
Hepatitis C* / drug therapy
-
Humans
-
Quinoxalines / adverse effects
-
Sofosbuvir / therapeutic use
-
Sustained Virologic Response
Substances
-
Antiviral Agents
-
Sofosbuvir
-
Benzimidazoles
-
Quinoxalines